Startup Mahakumbh 2024: Molecule AI set to showcase its cutting-edge drug discovery platform

New Delhi: Molecule AI, a company that works on integration of artificial intelligence with drug discovery, will showcase Molecule GEN, a cutting-edge drug discovery solution at the upcoming Startup Mahakumbh event from March 18-20, 2024, at Bharat Mandapam, New Delhi.

By integrating advanced AI algorithms with deep pharmaceutical expertise, Molecule GEN aims to significantly reduce the time and cost associated with bringing new, life-saving drugs to market.

“We are excited to introduce Molecule GEN at Startup Mahakumbh, a platform that aligns perfectly with our vision of transforming drug discovery through artificial intelligence,” said Saurabh Singal, CEO of Molecule AI. “Our participation in this event not only allows us to showcase our innovative solutions but also to engage with key stakeholders in the startup ecosystem and explore collaborative opportunities to further our mission.”

Startup Mahakumbh represents a unique convergence of India’s vibrant startup ecosystem, including an array of startups, investors, incubators, accelerators, and industry luminaries across diverse sectors.